Clinical Trials Directory

Trials / Completed

CompletedNCT00794443

ONO-5920/YM529 Confirmatory Study in Involutional Osteoporosis Patients

A Multi-center Double-blind Parallel-group Comparison Study in Involutional Osteoporosis Patients to Examine the Efficacy and Safety of ONO-5920/YM529 Monthly Intermittent Formulation With Its Daily Formulation.

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
692 (actual)
Sponsor
Astellas Pharma Inc · Industry
Sex
All
Age
45 Years
Healthy volunteers
Not accepted

Summary

This is a multi-center double-blind parallel-group study in involutional osteoporosis patients to compare the efficacy and safety of monthly oral intermittent formulation ONO-5920/YM529 with its daily formulation.

Conditions

Interventions

TypeNameDescription
DRUGYM529 / ONO-5920Oral

Timeline

Start date
2008-11-01
Primary completion
2010-04-01
Completion
2010-04-01
First posted
2008-11-20
Last updated
2015-05-04

Locations

5 sites across 1 country: Japan

Source: ClinicalTrials.gov record NCT00794443. Inclusion in this directory is not an endorsement.